42 results about "Irritable colon" patented technology

The invention discloses an intestine-moistening and bowel-relaxing composition. The intestine-moistening and bowel-relaxing composition comprises a probiotic compound and a prebiotic compound, whereinthe probiotic compound comprises the following components in parts by weight: 1-5 parts of lactobacillus acidophilus, 0.5-2 parts of bifidobacterium lactis, 0.5-4 parts of pediococcus acidilactici, 0.5-4 parts of bifidobacterium longum and 0.5-2 parts of lactobacillus plantarum; and the prebiotic compound comprises the following components in parts by weight: 3 to 40 parts of fructo-oligosaccharide, 2 to 30 parts of galacto-oligosaccharide, 0 to 30 parts of resistant dextrin, 0 to 20 parts of xylooligosaccharide, 0 to 30 parts of isomalto-oligosaccharide, 1 to 15 parts of inulin and 1 to 8 parts of stachyose. The invention also discloses an application of the composition and an intestine-moistening and bowel-relaxing solid beverage containing the composition. According to the composition,probiotics and prebiotics are combined, so that adhesion of pathogenic bacteria can be relieved, intestinal flora can be adjusted, and the incidence rate of irritable bowel comprehensive symptoms canbe remarkably reduced; and crowd food tasting experiments show that the composition has the effects of promoting defecation and relieving abdominal pain, abdominal distension and diarrhea symptoms.

Disclosed herein are exendin singly modified with polyethylene glycole or a derivative thereof, a method for the preparation of the same, and uses thereof. Exendin modified at lysine (27) with polyethylene glycol shows biological activity similar to that of natural exendin, but is improved in half life. In addition, the modification position and the number of PEG or its derivative are restricted so as to minimize the side effects caused by a variety of combinations of such factors. The exendin is useful in the prevention and treatment of diseases caused by the over-secretion of insulin, or diseases caused due to a decrease in plasma glucose level, the inhibition of gastric or intestinal motility, the promotion of satiety, or the inhibition of food intake, especially diabetes, obesity and irritable colon syndrome.

The invention discloses a probiotic solid beverage for relieving or treating irritable bowel syndrome. The product is prepared by mixing strains with excellent probiotic properties. A bacterial strainin the product comprises lactobacillus casei Zhang, bifidobacterium animalis subsp lactis V9, and lactobacillus plantarum P-8. The method comprises a step of carrying out correlation analysis on intestinal flora and activity index scores (IBSDAI) of patients of irritable bowel syndrome; the probiotic solid beverage can inhibit the growth of pathogenic bacteria by increasing the content of beneficial bacteria in intestinal tracts, the intestinal flora composition of patients is adjusted, and the effect of relieving or treating irritable bowel syndrome patients is achieved.

The invention discloses a medicament composition for treating spleen-insufficiency diarrhea type irritable bowel syndrome and a preparation method thereof. The medicament composition comprises 20-40 parts of primula sikkmensis hook, 10-20 parts of red ginseng, 10-20 parts of bighead atractylodes rhizome, 10-20 parts of poria cocos, 5-15 parts of dried tangerine peel, 5-15 parts of pinellia ternate and 3-6 parts of licorice roots. The preparation method comprises the following steps of: weighing the raw materials in proportion; soaking all raw materials of which the weight is 3-5 times that of water into the water for 1-2 hours; after soaking, adding water of which the weight is 2-3 times that of the raw materials, decocting for 1-1.5 hours, and filtering to obtain a water decoction at a first time after the decoction is finished; adding water of which the weight is 5-8 times that of the raw materials, decocting for 1-1.5 hours and filtering to obtain a water decoction at a second time; and mixing the water decoction at the first time with the water decoction at the second time. The medicament composition is novel in formula, simple in composition and low in cost; the preparation is easy to operate, low in preparation cost and suitable for industrial production; and the medicament is convenient to orally take and carry, has no toxic and side effects and has a good clinical curative effect for patients suffering from the spleen-insufficiency diarrhea type irritable bowel syndrome.

The invention relates to a medicine for treating spleen-deficiency diarrhea type IBS (Irritable Bowel Syndrome), which uses Chinese medical herbs as the raw material, and a manufacturing method of the medicine. At present, when the spleen-deficiency diarrhea type IBS is treated by western medicine, no special therapy or drugs can be used, the symptomatic treatment manner is mainly adopted clinically, the untoward effects are various and side effects are larger after long-term use of western medicines, the possibility of relapse is high after drug withdrawal, and the long-term follow-up result is poor. According to the invention, Codonopsis pilosula, atractylodes macrocephala, poria cocos, radix paeoniae alba, Rhizoma Pinellinae Praeparata, Saposhnikovia divaricata, dried tangerine or orange peel, humifuse euphorbia herb, liquorice and cortex albiziae are weighed by proportion, and ground into powder, so as to prepare a conventional medicament for oral use. Traditional Chinese medicines are used for achieving the effect of treating both manifestation and root cause of disease, the total effective rate is 96%, radical treatment is implemented based on pathology; the effect is ideal, side effects are avoided, and pain of patients suffering from the spleen-deficiency diarrhea type IBS can be relieved.

The present invention relates to a method for stereospecifically synthesizing 3-substituted 5-membered ring isomers of formula (A). The final product is useful in the treatment of epilepsy, syncope, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, gastrointestinal disorders such as irritable bowel syndrome (IBS), Medications for inflammation especially arthritis, sleep disorders, PMS, and hot flashes. The present invention provides a method for stereoselectively synthesizing gabapentin (Neurontin) analogues of formulas (I), (II), (III) and (IV) and pharmaceutically acceptable salts thereof, wherein R is C1-C10 alkyl Or C3-C10 cycloalkyl.

The invention discloses application of mir-146a-5p to treating visceral hypersensitivity of irritable bowel syndrome. The mir-146a-5p is low in expression in peripheral serum of patients with visceralhypersensitivity of irritable bowel syndrome and intestinal mucosa of disease model mice with irritable bowel syndrome; meanwhile, after the disease model mice of irritable bowel syndrome receive intraperitoneal injection of hsa-mir-146a-5p agomir to achieve high expression of mir-146a-5p, the visceral sensitivity of the disease model mice is significantly reduced, so that the effectiveness of mir-146a-5p on reducing visceral hypersensitivity of the irritable bowel syndrome can be proved, and an effective way for treating visceral hypersensitivity of irritable bowel syndrome can be provided.

Spiroindoline derivatives, process for their preparation and pharmaceutical compositions thereof, their use for the treatment and / or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and / or prophylaxis of diseases, especially sex-hormone-related diseases in both men and women, in particularly those selded from the group of endometriosis, uterine fibroids, polycystic ovarian disease, hirsutism, precocious puberty, gonadal steroid-dependent neoplasia such as cancers of the prostate, breast and ovary, gonadotrope pituitary adenomas, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hypertrophy, contraception and infertility (e.g., assisted reprodudive therapy such as in vitro fertilization). The present application relates in particular to spiroindoline derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists.

A minimally processed ready-to-eat legume / grain product is provided containing a significant amount of probiotic fiber and a probiotic source or is consumed with a probiotic source for the prevention and / or treatment of inflammatory chronic conditions such as inflammatory, autoimmune chronic conditions such as Irritable Bowel Syndrome (IBS), digestive disorders such chronic constipation, gastric acid reflux, diabetes, heart disease, obesity, some type of cancer, malabsorptive disorders, eczema as well mental health disorders such as anxiety disorder. The present invention is suitable for men and woman of all ages.

The invention discloses a traditional Chinese medicine composition for preventing and treating bacterial diarrhea of livestock and poultry, and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine composition comprises the following components in percentage by weight: 18-19% of coptis root, 14-15% of nutgall, 14-15% of pomegranate rind, 14-15% of myrobalam, 22-23% of astragalus mongholicus, 7-8% of atractylis ovata and 7-8% of radix sileris. The traditional Chinese medicine composition for preventing and treating bacterial diarrhea of livestock and poultry disclosed by the invention has significant curative effects on treating colibacillosis, salmonellosis and other bacterial diarrhea as well as chronic enteritis, irritable colon and other chronic diarrhea of the livestock and poultry. At the same time, the traditional Chinese medicine composition disclosed by the invention has the advantages of low production cost, and small toxic or side effect.

The invention discloses a plant composition capable of relieving diarrhea type irritable bowel syndrome, and belongs to the field of plant composition application. According to the plant composition, gynura procumbens is used as a main component, meanwhile, perilla frutescens, lophatherum gracile, platycodon grandiflorum and poria cocos are used as auxiliary components to jointly generate a synergistic effect, the symptoms of the diarrhea type irritable bowel syndrome can be remarkably improved and relieved, and the plant composition is safe and free of toxic and side effects. The invention also discloses a preparation method of the plant composition and a medicinal preparation which is prepared from the plant composition and can relieve diarrhea-type irritable bowel syndrome.

The invention discloses a plant composition capable of alleviating diarrhea-type irritable bowel syndrome, belonging to the application field of plant compositions. The botanical composition of the present invention is mainly composed of chrysanthemum notoginseng, supplemented with perilla, light bamboo leaves, platycodon grandiflorum and poria cocos, which can significantly improve and relieve the symptoms of diarrhea-type irritable bowel syndrome, and is safe. No toxic side effects. The invention also discloses a preparation method of the plant composition and a pharmaceutical preparation prepared from the plant composition which can relieve diarrhea-type irritable bowel syndrome.